185x Filetype PPTX File size 0.60 MB Source: www.esma.europa.eu
ESMA REGULAR USE Contents • Main findings • UCITS analysis – EU aggregate analysis – Analysis by management type – Funds by domicile • UCITS ESG analysis – Equity UCITS analysis – Analysis by ESG rating • SRPs analysis from PRIIPs – Performance scenario analysis – Costs analysis • Retail AIFs 2 ESMA REGULAR USE Main findings Retail clients continue to pay high costs for investment • UCITS funds – Costs only marginally declined over time – Retail clients paid around 40% more than institutional investors – Active net underperformance compared to passive – Outperformance of ESG funds mostly driven by sectoral factors • Structural Retail Products – Total costs attributable to entry costs and varied substantially by country and payoff type – Limited transparency and comparability across Member States. Heterogeneity and data availability issues persisted • Retail AIFs – Returns in 2019 higher than 2018 reflecting strong valuation of underlying assets 3 ESMA REGULAR USE Investment funds - UCITS, EU aggregate analysis Significant cost impact • Costs – Limited variability in costs – Cost impact is higher the lower is the performance: highest cost impact in 2016 and 2018 leading to negative net performance • Performance – Strong variations in annual performance reflecting market developments 4 ESMA REGULAR USE Investment funds - UCITS, analysis by management type Net underperformance of active funds • Equity funds: – Gross outperformance of passive and ETFs fades away at long horizons – However, costs significantly higher for active compared to passive and ETFs… – …so, underperformance of active UCITS, on average • Top performing funds: – Outperformance of the top-25% active compared to the top-25% passive at shorter horizons – The cohort changes over time making it complicated for investors to consistently identify outperforming UCITS 5 ESMA REGULAR USE Investment funds - UCITS, funds by domicile Fund- and investor-domicile analysis • Strong decline in heterogeneity moving from fund- to investor-domicile perspective 6
no reviews yet
Please Login to review.